Pre-market Movers: SCYX, DAIO, OMEX, CRSR, GPS…
The following are some of the stocks making big moves in Friday’s pre-market trading (as of 07.00 A.M. ET).
In the Green
Data I/O Corporation (DAIO) is up over 18% at $4.32
Odyssey Marine Exploration, Inc. (OMEX) is up over 15% at $6.43
Evolution Petroleum Corporation (EPM) is up over 12% at $7.91
Sonoma Pharmaceuticals, Inc. (SNOA) is up over 12% at $3.14
Chemomab Therapeutics Ltd. (CMMB) is up over 11% at $3.93
SK Telecom Co.,Ltd (SKM) is up over 9% at $29.99
Redbox Entertainment Inc. (RDBX) is up over 8% at $3.33
UFP Industries, Inc. (UFPI) is up over 7% at $82.90
Digital World Acquisition Corp. (DWAC) is up over 5% at $40.00
In the Red
SCYNEXIS, Inc. (SCYX) is down over 23% at $2.40
Corsair Gaming, Inc. (CRSR) is down over 14% at $15.60
The Gap, Inc. (GPS) is down over 14% at $12.27
Clarus Therapeutics Holdings, Inc. (CRXT) is down over 10% at $2.07
Autoliv, Inc. (ALV) is down over 7% at $71.61
Genfit SA (GNFT) is down over 7% at $3.79
Globus Medical, Inc. (GMED) is down over 5% at $74.80
Logitech International S.A. (LOGI) is down over 5% at $65.91
Service Properties Trust (SVC) is down over 5% at $8.31
Swvl Holdings Corp. (SWVL) is down over 5% at $5.94
Enservco Corporation (ENSV) is down over 5% at $2.83
Chevron Corp. Q1 Profit Increases, beats estimates
Chevron Corp. (CVX) reported a profit for its first quarter that increased from the same period last year and beat the Street estimates.
The company’s bottom line totaled $6.26 billion, or $3.22 per share. This compares with $1.38 billion, or $0.72 per share, in last year’s first quarter.
Excluding items, Chevron Corp. reported adjusted earnings of $6.54 billion or $3.36 per share for the period.
Analysts on average had expected the company to earn $3.27 per share, according to figures compiled by Thomson Reuters. Analysts’ estimates typically exclude special items.
The company’s revenue for the quarter rose 69.7% to $54.37 billion from $32.03 billion last year.
Chevron Corp. earnings at a glance (GAAP) :
-Earnings (Q1): $6.26 Bln. vs. $1.38 Bln. last year.
-EPS (Q1): $3.22 vs. $0.72 last year.
-Analyst Estimate: $3.27
-Revenue (Q1): $54.37 Bln vs. $32.03 Bln last year.
Watch Alexander Skarsgard Battle the Undead in ‘The Northman’
The director Robert Eggers narrates a scene that pits the star against a most unfriendly zombie.
Send any friend a story
As a subscriber, you have 10 gift articles to give each month. Anyone can read what you share.
By Mekado Murphy
Ghost of Kyiv hero of Ukraine war dies in battle defending country from Russians
We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info
More to follow…
FSIS Warns Against Trader Joe’s Certain RTE Frozen Chicken Products
The U.S. Department of Agriculture’s Food Safety and Inspection Service or FSIS has issued a public health alert for Trader Joe’s ready-to-eat or RTE frozen chicken products that did not receive the benefit of import reinspection.
The RTE frozen chicken products were produced on April 14 and 16, 2022. The agency noted that a recall was not requested because the products are no longer available for purchase.
The affected products include 12.5 oz. tray in-box packages containing “Trader Joes Butter Chicken With Basmati Rice” with best by dates of April 14, 2023, and April 16, 2023, and lot codes “208068” and “208228”; and 8.5 oz. bag in-box packages containing “Trader Joes Mini Chicken Tikka Samosas” with a best by date of April 14, 2023, and lot code “208072” and “207772.”
The products bear the Canadian establishment seal “913.” These items were shipped to Trader Joe’s locations in Idaho, Oregon, and Washington.
FSIS discovered the problem during its routine surveillance activities of imported products. There have been no confirmed reports of illness or adverse reactions due to consumption of these products.
FSIS is concerned that some product may be in consumers’ freezers. Consumers are urged to throw them away or return to the place of purchase.
AbbVie Q1 Income Rises
AbbVie (ABBV) released a profit for its first quarter that increased from the same period last year
The company’s earnings totaled $4.49 billion, or $2.51 per share. This compares with $3.55 billion, or $1.99 per share, in last year’s first quarter.
Excluding items, AbbVie reported adjusted earnings of $5.64 billion or $3.16 per share for the period.
The company’s revenue for the quarter fell 2.0% to $13.54 billion from $13.81 billion last year.
AbbVie earnings at a glance (GAAP) :
-Earnings (Q1): $4.49 Bln. vs. $3.55 Bln. last year.
-EPS (Q1): $2.51 vs. $1.99 last year.
-Revenue (Q1): $13.54 Bln vs. $13.81 Bln last year.
Full year EPS guidance: Adj: $13.92 – $14.12
Moog Inc. Q2 Adj. Profit Rises
Moog Inc. (MOG.A, MOG.B) reported second-quarter non-GAAP adjusted earnings per share of $1.49, up 12% from a year ago. On average, three analysts polled by Thomson Reuters expected the company to report profit per share of $1.28, for the quarter. Analysts’ estimates typically exclude special items.
Net earnings declined to $29.09 million or $0.91 per share from $48.69 million or $1.51 per share, prior year. Sales were $771 million, up 5% from a year ago. Analysts on average had estimated $758.21 million in revenue.
The company updated its fiscal 2022 projections and now projects: sales of $3.0 billion; GAAP earnings per share of $5.24, and adjusted earnings per share of $5.50, both plus or minus $0.20.
The Board has declared a quarterly dividend of $0.26 per share on the issued and outstanding shares of class A common stock and class B common stock. The dividend will be paid on May 31, 2022 to all shareholders of record as of the close of business on May 13, 2022.